Publication | Open Access

AP1G1 is involved in cetuximab-mediated downregulation of ASCT2-EGFR complex and sensitization of human head and neck squamous cell carcinoma cells to ROS-induced apoptosis

Asct2-egfr ComplexTumor BiologyOncogenic AgentMedicineApoptosisCell DeathPathologyHuman HeadHead And Neck CancerCetuximab-mediated DownregulationTumor SuppressorOncologyCell BiologyCancer Research